May 30 (Reuters) - Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court accusing the company of scheming to delay a generic version of its schizophrenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback